|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 影响卒中死亡率下降的因素美国心脏协会/美国卒中协会的科学声明显示文摘背景和目的 美国的卒中死亡率自20世纪初以来一直呈下降趋势,尽管这种“下降”很受欢迎,但其原因尚不完全清楚.由于近年来卒中死亡率呈现出更为显著的加速下降趋势,卒中已从美国的第3位死亡原因下降至第4位.这促使人们对影响卒中发病风险和死亡率变化的相关因素进行详细评估.这份声明对有关卒中死亡率下降趋势的促进因素的研究证据进行回顾,并讨论了将来如何利用这些因素在卒中这一重大公共卫生问题的干预研究中发挥作用.方法 写作组成员由委员会主席和副主席根据其以前在相关领域的研究成果提名,并通过美国心脏协会(American Heart Association,AHA)卒中委员会的科学声明监督委员会和美国心脏协会手稿监督委员会批准.作者利用系统文献综述,参考公开发表的临床和流行病学研究、发病率和死亡率报告、临床与公共卫生指南、权威声明、个人文件以及专家意见,对相关证据进行总结并指出与当前知识水平的差距.所有写作组成员均有机会评论这份声明并批准其最终版本.这份声明经过AHA内部的广泛同行评议以及卒中委员会领导阶层和科学声明监督委员会的审查,然后获得AHA科学顾问与协调委员会的批准.结果 过去数十年间,在不同性别、所有种族/民族以及各个年龄组人群中都观察到卒中死亡率的下降,这体现出人群健康的重大进展.除了卒中对于总体寿命损失的影响减少外,在65岁以下人群中观察到的卒中死亡率显著下降体现了其所致潜在寿命损失年的减少.卒中死亡率的下降要归功于卒中发病率和病死率的降低.这些卒中转归的显著改善与心血管危险因素的控制和干预相一致.虽然很难计算出具体的归因危险度估计值,但始于20世纪70年代的血压控制措施似乎已对卒中死亡率的加速下降产生了最实质性的影响.尽管实施较晚,但糖尿病和血脂异常控制以及戒烟计划,特别是联合降压治疗,似乎同样促进了卒中死亡率的下降.远程医疗和卒中医疗体系也似乎具有强烈的潜在作用,但尚需足够长的时间来证明其对卒中死亡率下降的影响.其他因素也可能产生影响,但需要更多的研究来确定它们的作用.结论 卒中死亡率的下降是真实存在的,代表着公共卫生以及临床医学的巨大成功.卒中从第3位死亡原因下降至第4位是死亡率真实下降的结果,而并非由于慢性肺病死亡率上升所致,后者是目前在美国是第3位的死亡原因.有强烈的证据表明,卒中死亡率的下降可归功于以科学发现为基础、旨在降低卒中风险而执行的联合干预措施和项目,其中最有可能的是对高血压控制的改善.因此,对正在开展的干预项目进行的研究及其成果的应用已改善了人群健康.对一些积极的循证公共卫生项目以及临床干预措施的持续应用预期会进一步降低卒中死亡率. | Daniel T.Lackland Edward J.Roccella Anne F.Deutsch Myriam Fornage Mary G.George George Howard Brett M.Kissela Steven J.Kittner Judith H.Lichtman Lynda D. Lisabeth Lee H. Schwamm Eric E. Smith 高一鹭 陈政弘 王文志 | 2014 | 国际脑血管病杂志2014，22，5： | 41 |
| 2 | Evolving concepts in bone infection: redefining “biofilm”,“acute vs. chronic osteomyelitis”, “the immune proteome” and “local antibiotic therapy”显示文摘Osteomyelitis is a devastating disease caused by microbial infection of bone. While the frequency of infection following elective orthopedic surgery is low, rates of reinfection are disturbingly high. Staphylococcus aureus is responsible for the majority of chronic osteomyelitis cases and is often considered to be incurable due to bacterial persistence deep within bone. Unfortunately, there is no consensus on clinical classifications of osteomyelitis and the ensuing treatment algorithm. Given the high patient morbidity,mortality, and economic burden caused by osteomyelitis, it is important to elucidate mechanisms of bone infection to inform novel strategies for prevention and curative treatment. Recent discoveries in this field have identified three distinct reservoirs of bacterial biofilm including: Staphylococcal abscess communities in the local soft tissue and bone marrow, glycocalyx formation on implant hardware and necrotic tissue, and colonization of the osteocyte-lacuno canalicular network(OLCN) of cortical bone. In contrast, S.aureus intracellular persistence in bone cells has not been substantiated in vivo, which challenges this mode of chronic osteomyelitis. There have also been major advances in our understanding of the immune proteome against S. aureus, from clinical studies of serum antibodies and media enriched for newly synthesized antibodies(MENSA), which may provide new opportunities for osteomyelitis diagnosis, prognosis, and vaccine development. Finally, novel therapies such as antimicrobial implant coatings and antibiotic impregnated 3D-printed scaffolds represent promising strategies for preventing and managing this devastating disease. Here, we review these recent advances and highlight translational opportunities towards a cure. | Elysia A. Masters Ryan P. Trombetta Karen L. de Mesy Bentley Brendan F Boyce Ann Lindley Gill Steven R. Gill Kohei Nishitani Masahiro Ishikawa Yugo Morita Hiromu Ito Sheila N. Bello-Irizarry Mark Ninomiya James D. Brodell Jr. Charles C. Lee Stephanie P. Hao Irvin Oh Chao Xie Hani A. Awad John L. Daiss John R. Owen Stephen L. Kates Edward M. Schwarz Gowrishankar Muthukrishnan | 2019 | Bone Research2019，7，3： | 19 |
| 3 | Targeting cannabinoid signaling for peritoneal dialysisinduced oxidative stress and fibrosis显示文摘Long-term exposure to bioincompatible peritoneal dialysis(PD) solutions frequently results in peritoneal fibrosis and ultrafiltration failure,which limits the life-long use of and leads to the cessation of PD therapy.Therefore,it is important to elucidate the pathogenesis of peritoneal fibrosis in order to design therapeutic strategies to prevent its occurrence.Peritoneal fibrosis is associated with a chronic inflammatory status as well as an elevated oxidative stress(OS) status.Beyond uremia per se,OS also results from chronic exposure to high glucose load,glucose degradation products,advanced glycation end products,and hypertonic stress.Therapy targeting the cannabinoid(CB) signaling pathway has been reported in several chronic inflammatory diseases with elevated OS.We recently reported that the intra-peritoneal administration of CB receptor ligands,including CB_1 receptor antagonistsand CB_2 receptor agonists,ameliorated dialysis-related peritoneal fibrosis.As targeting the CB signaling pathway has been reported to be beneficial in attenuating the processes of several chronic inflammatory diseases,we reviewed the interaction among the cannabinoid system,inflammation,and OS,through which clinicians ultimately aim to prolong the peritoneal survival of PD patients. | Chih-Yu Yang Yat-Pang Chau Ann Chen Oscar Kuang-Sheng Lee Der-Cherng Tarng An-Hang Yang | 2017 | World Journal of Nephrology2017，6，3： | 13 |
| 4 | 新生儿复苏培训降低新生儿死亡率的效能分析:文献综述,meta分析与Delphi法的应用显示文摘[背景]全球每年13600万新生儿中,约1000万需要外界的帮助才能建立自主呼吸,每年有约814000例新生儿死亡是由分娩相关足月儿死亡(以往定义为'出生窒息')所导致的。目前尚缺乏关于新生儿复苏培训降低新生儿死亡率效能的系统性评价。[目的]对在医院和社区层面开展的快速评估及初步刺激、基本的复苏措施这两种新生儿复苏培训干预方法在降低足月新生儿分娩相关死亡率('出生窒息')、早产相关并发症死亡率这两个生命指标方面的效能进行评价。[方法]采用系统综述的方法,检索并筛选符合标准的新生儿复苏培训研究文献。采用GRADE方法对文献的质量进行评价。对符合要求的文件进行Meta分析。对数据质量较低的文献采用专家咨询法估计效能大小。[结果]通过文献检索筛选了24篇新生儿复苏培训干预研究(20篇观察性研究,2篇半试验研究,2篇随机对照研究)。对其中3篇文献进行Meta分析结果显示,以医院为基础的新生儿复苏培训可使分娩相关足月儿死亡降低30%(RR=0.70,95%CI0.59~0.84);文献中涉及早产儿死亡率效能的数据质量不高,因此采用专家咨询法进行估计。以社区为基础的新生儿复苏培训干预研究具有较高的异质性,复苏培训通常是一系列培训包的一部分,且对早产儿和足月儿的定义标准不一致。专家咨询法估计结果显示,新生儿快速评估和初步刺激可使分娩相关新生儿死亡、早产儿死亡均降低10%;以医院为基础的培训可使早产儿死亡进一步降低10%,以社区为基础的培训可使分娩相关足月儿死亡率进一步降低20%,早产儿死亡率进一步降低5%。[结论]新生儿复苏培训在医院层面可以使足月新生儿分娩相关死亡率降低30%,然而中低收入水平的国家培训覆盖率仍较低。专家咨询法估计新生儿复苏培训在社区层面降低足月儿及早产儿死亡率的效能较小。需要对新生儿复苏培训的效果、成本、实施策略等进行更深入的研究与评价。 | Anne CC Lee Simon Cousens Stephen N Wall 徐韬 | 2012 | 中国妇幼卫生杂志2012，3，2： | 11 |
| 5 | Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma显示文摘 | Masao Omata Laurentius A. Lesmana Ryosuke Tateishi Pei-Jer Chen Shi-Ming Lin Haruhiko Yoshida Masatoshi Kudo Jeong Min Lee Byung Ihn Choi Ronnie T. P. Poon Shuichiro Shiina Ann Lii Cheng Ji-Dong Jia Shuntaro Obi Kwang Hyub Han Wasim Jafri Pierce Chow Seng | 2010 | Hepatology International2010，，2： | 11 |
| 6 | Molecular targets in the treatment of alcoholic hepatitis显示文摘Alcohol related costs to health and society are high. One of the most serious complications of alcohol misuse to the individual is the development of alcoholic hepatitis (AH), a clinical syndrome of jaundice and progressive inflammatory liver injury in patients with a history of recent heavy alcohol use. It has a poor outcome and few existing successful therapies. The use of glucocorticoids in patients with severe AH is still controversial and there remains a group of patients with glucocorticoid-resistant disease. However, as our understanding of the pathogenesis of the condition improves there are opportunities to develop new targeted therapies with specific actions to control liver inflammation without having a detrimental effect on the immune system as a whole. In this article we review the molecular mechanisms of AH concentrating on the activation of the innate and adaptive immune response. We consider existing treatments including glucocorticoids, anti-tumor necrosis factor therapy and pentoxifylline and their limitations. Using our knowledge of the disease pathogenesis we discuss possible novel therapeutic approaches. New targets include pro-inflammatory cytokines such as interleukin (IL)-17, chemokines and their receptors (for example IL-8, CXCL9 and CXCR3) and augmentation of anti-inflam- matory molecules such as IL-10 and IL-22. And there is also future potential to consider combination therapy to selectively modulate the immune response and gain control of disease. | Ashwin D Dhanda Richard WL Lee Peter L Collins C Anne McCune | 2012 | World Journal of Gastroenterology2012，18，39： | 9 |
| 7 | Neuroimaging the brain-gut axis in patients with irritable bowel syndrome显示文摘AIM:To summarize and synthesize current literature on neuroimaging the brain-gut axis in patients with irritable bowel syndrome(IBS).METHODS:A database search for relevant literature was conducted using Pub Med,Scopus and Embase in February 2015.Date filters were applied from the year2009 and onward,and studies were limited to those written in the English language and those performed upon human subjects.The initial search yielded 797articles,out of which 38 were pulled for full text review and 27 were included for study analysis.Investigations were reviewed to determine study design,methodology and results,and data points were placed in tabular format to facilitate analysis of study findings across disparate investigations.RESULTS:Analysis of study data resulted in the abstraction of four key themes:Neurohormonal differences,anatomic measurements of brain structure and connectivity,differences in functional responsiveness of the brain during rectal distention,and confounding/correlating patient factors.Studies in this review noted alterations of glutamate in the left hippocampus(HIPP),commonalities across IBS subjects in terms of brain oscillation patterns,cortical thickness/gray matter volume differences,and neuroanatomical regions withincreased activation in patients with IBS:Anterio cingulate cortex,mid cingulate cortex,amygdala anterior insula,posterior insula and prefrontal cortex.A striking finding among interventions was the substantia influence that patient variables(e.g.,sex,psychologica and disease related factors)had upon the identification of neuroanatomical differences in structure and con nectivity.CONCLUSION:The field of neuroimaging can provide insight into underlying physiological differences that distinguish patients with IBS from a healthy population. | Kristen R Weaver Lee Anne B Sherwin Brian Walitt Gail D'Eramo Melkus Wendy A Henderson | 2016 | World Journal of Gastrointestinal Pharmacology and Therapeutics2016，7，2： | 8 |
| 8 | Collision tumor of hepatocellular carcinoma and neuroendocrine carcinoma involving the liver: Case report and review of the literature显示文摘Primary hepatic neuroendocrine carcinoma(NEC) with concurrent occurrence of hepatocellular carcinoma(HCC) of the liver is very rare. Only 8 cases have been reported in the literature. Concurrent occurrence of HCC and NEC in the liver is classified as combined type or collision type by histological distributional patterns; only 2 cases have been reported. Herein, we report a case of collision type concurrent occurrence of HCC and NEC, in which primary hepatic NEC was in only a small portion of the nodule, which is different from the 2 previously reported cases. A 72-year-old male with chronic hepatitis C was admitted to our hospital for a hepatic mass detected by liver computed tomography(CT) at another clinic. Because the nodule was in hepatic segment 3 and had proper radiologic findings for diagnosis of HCC, including enhancement in the arterial phase and wash-out in the portal and delay phases, the patient was treated with laparoscopic left lateral sectionectomy. The pathology demonstrated that the nodule was 2.5 cm and was moderately differentiated HCC. However, a 3 mm-sized focal neuroendocrine carcinoma was also detected on the capsule of the nodule. The tumor was concluded to be a collision type with HCC and primary hepatic NEC. After the surgery, for follow-up, the patient underwent a liver CT every 3 mo. Five multiple nodules were found in the right hepatic lobe on the follow-up liver CT 6 mo post-operatively. As the features of the nodules in the liver CT and MRI were different from that of HCC, a liver biopsy was performed. Intrahepatic recurrent NEC was proven after the liver biopsy, which showed the same pathologic features with the specimen obtained 6 mo ago. Palliative chemotherapy with a combination of etoposide and cisplatin has been administered for 4 months, showing partial response. | Gyu Ho Choi Sun Young Ann Soon Il Lee Suk BaeKim Il Han Song | 2016 | World Journal of Gastroenterology2016，22，41： | 8 |
| 9 | 国外自闭症谱系障碍儿童远程诊疗:现状与启示显示文摘自新冠疫情爆发以来,各国加大了对自闭症儿童远程诊疗的研究和实践。本文对2010-2021年间国外自闭症谱系障碍儿童远程诊疗的研究案例作了梳理,从技术手段、诊疗对象、诊疗措施和治疗效果等几个方面进行实证分析,发现远程诊疗在提升患儿言语语言交流能力、日常生活技能、社交技能和行为管理能力方面都产生了实际疗效。此外,远程指导下的治疗结束后家长和患儿的压力和焦虑情绪得到极大缓解、家长满意度高且坚持训练项目的意愿较为强烈。最后,本文对自闭症儿童远程诊疗在我国的发展作了积极展望,以期为疫情下国内自闭症儿童的诊疗提供思路和启发。 | 陈雯珺 余英 Sue Ann Lee 马博森 | 2022 | 中国特殊教育2022，，1： | 7 |
| 10 | Identification of Arabidopsis MYB56 as a Nove Substrate for CRL3BPM E3 Ligases显示文摘蛋白质的控制稳定性是高度有效的机制在生活房间指导多样的过程。一 ? 为蛋白质稳定性的关键规章的系统被 ubiquitin proteasome 小径给,它使用 E3 ligases 为降级标记特定的蛋白质。在这个工作,当 CULLIN3 (CUL3 ) 的一个新奇目标基于 E3 ligase, MYB56 被识别。它的稳定性取决于 MATH-BTB/POZ (BPM ) 蛋白质的存在,它作为底层适配器工作到 E3 ligase。基因研究显示了 MYB56 是 ? 一 ? flowering 的否定管理者,当 BPM 断然影响这个发展程序时。在 BPM 和 MYB56 之间的相互作用发生在 FLOWERING 的倡导者地点 T (英尺) ,在在 Arabidopsis 开始 flowering 的一个关键管理者,和在 MYB56 的不稳定性的结果。总的来说,工作作为 BPM 蛋白质的底层建立 MYB 抄写因素,并且在参予在工厂控制 flowering 时间的部件上提供新奇信息。 | Liyuan Chen Anne Bernhardt JooHyun Lee Hanjo Hellmann | 2015 | Molecular Plant2015，8，2： | 6 |
| 11 | Emerging radiotherapy technologies and trends in nasopharyngeal cancer显示文摘AbTechnology has always driven advances in radiotherapy treatment.In this review,we describe the main technological advances in radiotherapy over the past decades for the treatment of nasopharyngeal cancer(NPC)and highlight some of the pressing issues and challenges that remain.We aim to identify emerging trends in radiation medicine.These include advances in personalized medicine and advanced imaging modalities,standardization of planning and delineation,assessment of treatment response and adaptive re-planning,impact of particle therapy,and role of artificial intelligence or automation in clinical care.In conclusion,we expect significant improvement in the therapeutic ratio of radiotherapy treatment for NPC over the next decade. | Michelle Tseng Francis Ho Yiat Horng Leong Lea ChoungWong Ivan WK Tham Timothy Cheo Anne WM Lee | 2020 | Cancer Communications2020，40，9： | 5 |
| 12 | 关于与青光眼疾病严重性相关的资源使用和成本的一项多中心回顾性试验研究显示文摘目的:调查在不同疾病严重程度上青光眼治疗的资源消耗和直接成本。
设计:基于医学档案综述的观察性、回顾性的队列研究。 | Paul P. Lee John G. Walt John J. Doyle Sameer V. Kotak Stacy J. Evans Donald L. Budenz Philip P. Chen Anne L. Coleman Robert M. Feldman HenRY D. Jampel L.Jay Katz Richard P.Mills Jonathan S.Myers Robert J.Noecker Jody R.Piltz-Seymour Robert R.Ritch Paul N.Schacknow Janet B.Serle Gary L.Trick 范翔(译) | 2006 | 美国医学会眼科杂志(中文版)2006，18，4： | 4 |
| 13 | Update on Cardiovascular Implantable Electronic Device Infections and Their Management: A Scientific Statement From the American Heart Association显示文摘 | Larry M. Baddour Andrew E. Epstein Christopher C. Erickson Bradley P. Knight Matthew E. Levison Peter B. Lockhart Frederick A. Masoudi Eric J. Okum Walter R. Wilson Lee B. Beerman Ann F. Bolger N A. Mark Estes Michael Gewitz Jane W. Newburger Eleanor B. S | 2010 | Circulation2010，，3： | 4 |
| 14 | Deletion of IFT20 in early stage T lymphocyte differentiation inhibits the development of col agen-induced arthritis显示文摘IFT20 is the smallest member of the intraflagellar transport protein(IFT) complex B. It is involved in cilia formation. Studies of IFT20 have been confined to ciliated cells. Recently, IFT20 was found to be also expressed in non-ciliated T cells and have functions in immune synapse formation and signaling in vitro. However, how IFT20 regulates T-cell development and activation in vivo is still unknown. We deleted the IFT20 gene in early and later stages of T-cell development by crossing IFT20flox/flox(IFT20f/f) mice with Lck-Cre and CD4-Cre transgenic mice, and investigated the role of IFT20 in T-cell maturation and in the development of T cell-mediated collagen-induced arthritis(CIA). We found that both Lck-Cre/IFT20f/f and CD4-Cre/IFT20f/f mice were indistinguishable from their wild-type littermates in body size, as well as in the morphology and weight of the spleen and thymus. However, the number of CD4- and CD8-positive cells was significantly lower in thymus and spleen in Lck-Cre/IFT20f/f mice. Meanwhile, the incidence and severity of CIA symptoms were significantly decreased, and inflammation in the paw was significantly inhibited in Lck-Cre/IFT20f/f mice compared to Lck-Cre/IFT201/1littermates. Deletion IFT20 in more mature T cells of CD4-Cre/IFT20f/f mice had only mild effects on the development of T cells and CIA. The expression of IL-1b, IL-6 and TGF-b1 were significantly downregulated in the paw of Lck-Cre/IFT20f/f mice, but just slight decreased in CD4-Cre/IFT20f/f mice. These results demonstrate that deletion of IFT20 in the early stage of T-cell development inhibited CIA development through regulating T-cell development and the expression of critical cytokines. | Xue Yuan Lee Ann Garrett-Sinha Debanjan Sarkar Shuying Yang | 2014 | Bone Research2014，2，4： | 4 |
| 15 | Transanal colorectal resection using natural orifice translumenal endoscopic surgery ( NOTES )显示文摘 | Isha Ann Emhoff Grace Clara Lee Patricia Sylla | 2014 | Digestive Endoscopy2014，，： | 3 |
| 16 | 未来十年航空维修市场预测显示文摘尽管航空公司的客座收益率增加了,但降低维修成本的压力仍在继续,发动机维修市场反弹最为强劲。TeamSAI公司今年继续为本刊提供了未来10年的航空维修市场预测数据,预计今年的全球航空维修市值会达到469亿美元,比2010年高出10.8%。MRO市场的复苏通常较航空运输业的回暖要滞后12~18个月。 | Lee Ann Tegtmeier 成磊 | 2011 | 航空维修与工程2011，，3： | 3 |
| 17 | Impact of a trimodal prehabilitation program on functional recovery after colorectal cancer surgery: a pilot study显示文摘 | Chao Li Francesco Carli Lawrence Lee Patrick Charlebois Barry Stein Alexander S. Liberman Pepa Kaneva Berson Augustin Mingkwan Wongyingsinn Ann Gamsa Do Jun Kim Melina C. Vassiliou Liane S. Feldman | 2013 | Surgical Endoscopy2013，，4： | 3 |
| 18 | Evaluation of a locked nucleic acid form of antisense oligo targeting HIF-1α in advanced hepatocellular carcinoma显示文摘BACKGROUND Hypoxia-inducible factor 1α(HIF-1α) is a gene that regulates tumor survival,neovascularization and invasion. Overexpression of HIF-1α correlates with poor prognosis in hepatocellular carcinoma(HCC). RO7070179 is a HIF-1α inhibitor that decreases HIF-1α mRNA and its downstream targets, it could be a potential treatment in HCC.AIM To evaluate safety and preliminary activity of RO7070179 in patients with previously treated HCC, with focus on a patient with prolonged response to RO7070179.METHODS In the preclinical study of RO7070179 in a HCC xenograft model, the mice wereseparated into 4 groups with each group received doses of 0, 3, 10 and 30 mg/kg for total 10 doses. HCC patients who failed at least one line of systemic treatment,received RO7070179 as a weekly infusion, each cycle is 6 wk. We evaluated the safety and HIF-1α mRNA levels of RO7070179.RESULTS Preclinical evaluation of RO7070179 in orthotopic HCC xenograft model showed no significant differences in HCC tumor weight between the 3 and 10 mg/kg groups. However, dose of 10 mg/kg of RO7070179, has shown 76% reduction of the amount of HIF-1α mRNA in HCC tissue. In the phase 1 b study of RO7070179 in previously treated HCC patients, 8 out of 9 were evaluable: 1 achieved PR and1 SD. The patient with PR responded after 2 cycles treatments, which has been maintained for 12 cycles. This patient also showed reduction in perfusion of dynamic contrast-enhanced magnetic resonance imaging(DCE-MRI) after 1 cycle of treatment. After 1 cycle of treatment, both patients with PR and SD showed decrease in HIF-1α mRNA at the root of biopsies(each biopsy was divided into 2 specimens, the tip and the root).CONCLUSION RO7070179 can reduce HIF-1α mRNA level in HCC patients with SD or PR. It is well tolerated at 10 mg/kg, with transaminitis as the dose of increased toxicity.This study indicates that RO7070179 might benefit HCC patients, and an early signal for clinical benefit can potentially be predicted through changes in either m RNA level or DCE-MRI within 1 cycle of therapy. | Jennifer Wu Merly Contratto Krishna P Shanbhogue Gulam A Manji Bert H O'Neil Anne Noonan Robert Tudor Ray Lee | 2019 | World Journal of Clinical Oncology2019，10，3： | 2 |
| 19 | 航空业基于大数据的预测维修发展现状显示文摘飞机从设计诞生到运营维护全生命周期内会生成大量的数据,尤其是新一代飞机,产生的数据量很大。各类制造商和数据运营商都在打数据的主意,希望通过数据采集、机器学习、模型分析、加装传感器等手段丰富各自的预测维修系统,实现更好地健康监控。在此过程中,行业对于基于大数据的预测维修的理解和感悟也在变得越来越深入,越来越贴合实际需要。 | Lee Ann Shay Sean Broderick 淦家杭(译) | 2019 | 航空维修与工程2019，0，8： | 2 |
| 20 | The battle against nasopharyngeal cancer显示文摘 | Anne W.M. Lee W.T. Ng Y.H. Chan Henry Sze Connie Chan T.H. Lam | 2012 | Radiotherapy and Oncology2012，，3： | 2 |
您所在的机构暂未开通此部分的功能，请联系管理员